Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MariMed Inc. (MRMD : OTC)

• Company Description    MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass. Number of Employees: 832

• Price / Volume Information    Yesterday's Closing Price: $0.09 Daily Weekly Monthly 20 Day Moving Average: 1,870,238 shares Shares Outstanding: 395.60 (millions) Market Capitalization: $37.19 (millions) Beta: 1.04 52 Week High: $0.23 52 Week Low: $0.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.50% 17.70% 12 Week -42.86% -43.78% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 Oceana Way - Norwood,MA 02062 USA ph: 781-277-0007 fax: - ir@marimedinc.com http://www.marimedinc.com

• General Corporate Information    Officers Jon R. Levine - Chief Executive Officer and President Edward Gildea - Chairman of the Board and Director Mario Pinho - Chief Financial Officer David Allen - Director Eva Selhub - Director Peer Information MariMed Inc. (BJCT) MariMed Inc. (CADMQ) MariMed Inc. (APNO) MariMed Inc. (UPDC) MariMed Inc. (IMTIQ) MariMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 56782V107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/04/26 Share - Related Items Shares Outstanding: 395.60 Most Recent Split Date: (:1) Beta: 1.04 Market Capitalization: $37.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.01 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.68 Price/Cash Flow: 4.36 Price / Sales: 0.24 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 0.43% vs. Previous Quarter: 2.91% ROE 12/31/25 - - 09/30/25 - -14.67 06/30/25 - -10.52 ROA 12/31/25 - - 09/30/25 - -4.12 06/30/25 - -3.10 Current Ratio 12/31/25 - - 09/30/25 - 1.06 06/30/25 - 1.12 Quick Ratio 12/31/25 - - 09/30/25 - 0.35 06/30/25 - 0.36 Operating Margin 12/31/25 - - 09/30/25 - -5.41 06/30/25 - -4.10 Net Margin 12/31/25 - - 09/30/25 - -11.36 06/30/25 - -10.14 Pre-Tax Margin 12/31/25 - - 09/30/25 - -4.20 06/30/25 - -4.30 Book Value 12/31/25 - - 09/30/25 - 0.14 06/30/25 - 0.15 Inventory Turnover 12/31/25 - - 09/30/25 - 2.59 06/30/25 - 2.66 Debt-to-Equity 12/31/25 - - 09/30/25 - 1.34 06/30/25 - 1.25 Debt-to-Capital 12/31/25 - - 09/30/25 - 57.35 06/30/25 - 55.57

Powered by Zacks Investment Research ©